MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov. 8, 2017--
GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD,
Executive Chairman, will present a company overview at the Stifel 2017
Healthcare Conference on Wednesday, November 15, 2017 at 9:30 am EST.
The conference is being held at the Lotte New York Palace Hotel in New
A simultaneous webcast of the presentation can be accessed by visiting
the investor relations section of the GTx website at http://www.gtxinc.com.
A replay of the presentation will also be available and archived on the
site for 30 days.
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical
company dedicated to the discovery, development and commercialization of
small molecules for the treatment of serious medical conditions,
including treatments for stress urinary incontinence and prostate cancer.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005339/en/
Source: GTx, Inc.
Kimberly Minarovich or Sam
Red House Consulting